Generics 17

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Doripenem manufacturers

17 products found

Filters

17 products found

doripenem

Injection 250 mg, 500 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #18256
This pharmaceutical company specializes in a wide range of products including prescription medications, over-the-counter drugs, and supplements. They focus on key therapy areas such as anti-infectives, anesthesiology, gastroenterology, pain management, nephrology, gynecology, and vitamin/mineral nutrition. Their manufacturing facilities are equipped to produce various dosage forms and hold relevant GMP certifications. The company has a strong presence in Asia with plans for international expansion. They actively pursue product development and hold patents for key medications.

Manufacturer usually replies in 26 days

doripenem

Solution for injection/infusion 500 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #17147
This company is a global provider of cleaning and disinfecting solutions specifically designed for hospitals and healthcare providers. Founded in 2003, they specialize in enzymatic detergents and offer a range of non-enzymatic and specialist detergents to address various medical cleaning needs. Their product portfolio includes pre-cleaning sprays, detergents, neutralizers, lubricants, and disinfectants, with a focus on environmentally friendly solutions meeting greenworks standards. The company emphasizes the efficacy of enzymes for cleaning and boasts extensive knowledge in this area. They collaborate with leading decontamination experts and provide educational resources to optimize medical device cleaning processes. Their commitment to quality is evident in their product development and customer satisfaction. They cater to key regions such as North America, Europe, and Asia, offering competitive pricing without compromising on clinical efficacy and performance.

Manufacturer usually replies in 16 days

doripenem

Vials 500 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #10323
This company is a global manufacturer of essential lifesaving medicaments, specializing in high-tech parenteral and oral formulations. Established in 1984, it has grown from a small family business to a multinational corporation with over 2000 employees across 70 markets. Their expertise spans various therapeutic areas including anaesthesiology, critical care, pain management, gynaecology, ophthalmology, orthopaedics, oncology, and dermatology. They offer a diverse product portfolio of over 500 products, including injectables, infusions, and other dosage forms. The company prides itself on its commitment to quality, innovation, ethics, and transparency. They maintain GMP certifications and hold patents for several products. Their manufacturing sites are strategically located across key regions like the EU and North America.

Manufacturer usually replies in 13 days

Want to see all 17 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Doripenem

Doripenem is an antibiotic of the Carbapenem class. It is a beta-lactam antibiotic capable of killing Pseudomonas aeruginosa. Doripenem is used to treat bacterial infections namely complex abdominal infections, pneumonia contracted in hospital, and complicated infections of the urinary tract including sepsis in the kidney infection. It has greater stability in aqueous solution compared to other Carbapenem class antibiotics. Doripenem is administered as an infusion over 4 hours or more, which is an advantage when treating difficult-to-treat infections. It also has a lower risk associated with inducing seizures than other Carbapenem. Doripenem is sold under the brand names Doribax and Finibax amongst others. Shionogi Co. of Japan launched it under the brand name in 2005 and is marketed outside Japan by Johnson & Johnson. Doripenem was approved by the USFDA in 2007, to be sold as Doribax. It is the fourth carbapenem class drug to get approval in the United States. USFDA later revised the Doripenem label in 2014 to include a warning against use in ventilator-associated pneumonia while reiterating its safety and efficacy for its approved indications.

Forms and Dosage

Doripenem is sold as a powder for injection in a 500 mg vial. In the treatment of Complicated Intra- abdominal Infection, the prescribed adult dosage is 500 mg IV infusion over 1 hour, given every 8hr for 5-14 days. if there is an improvement in the condition, the doctor may switch to PO treatment. In the treatment of Complicated UTI, the standard prescribed dose is 500 mg IV infusion over 1 hour given every 8 hours for 10 days, which can be extended up to 14 days if needed. In the treatment of Bronchopulmonary infection in patients with cystic fibrosis and who are colonized with Pseudomonas aeruginosa or Burkholderia cepacia.

The Price of Doripenem

In the USA, the consumers pay around $182 for Doripenem intravenous powder for injection 250 mg for a supply of 10 powder for injection. In the developing world countries, especially in India, the medicine is significantly cheaper with the generic versions, with a starting price of the only USD20 for the same 500 mg vial of powder for injection.

How does Doripenem work?

Doripenem is a beta-lactam antibiotic agent with a broad spectrum of bacterial sensitivity including both gram-positive and gram-negative bacteria. In vivo, Doripenem blocks the synthesis of cell walls by attaching itself to penicillin-binding proteins, But, it is not active against MRSA. Just like other beta- lactam antibiotics, Its bactericidal actions mostly due to cell death after inhibition of bacterial enzymes called penicillin-binding proteins.

Finding Doripenem Manufacturers and Suppliers

The process of finding trusted Doripenem manufacturers and Doripenem suppliers can be made quicker and more accessible by using Pipelinepharma's online platform, a B2B marketplace that lets you finalize the deals of pharmaceutical products in a matter of a few clicks. Also, it is an easy to use online platform to grow your business opportunities. The robust search engine makes it convenient to search for manufacturers and suppliers of Doripenem. The search can be further refined with industry-specific filters such as dossier type, country of origin, GMP approvals, and search criteria for Wholesaler, etc. helping to get in contact with the preferred manufacturer and supplier readily.

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible